See also: HIV and the Immune System; Cell Therapy and HIV; Gene Therapy and HIV; Interleukin-2; and Vaccines to Prevent or Treat HIV Infection

General Information

• Immune Restoration (AIDS InfoNet) and Spanish version
• Immunotherapy (AIDSInfo) and Spanish version
• Passive immunotherapy (AIDSInfo) and Spanish version
• Interleukin-2 (AIDS Infonet) and Spanish version

Selected Recent Articles

• Gilead Signs Deal With Biotech Company to Develop HIV Antibody Treatment.  (August 2016, Poz)
• HIV Cure Research Strategies.  (July 2016, TheBodyPro)
• Pediatric HIV Cure Studied in Infant Monkeys.  (July 2016, TheBodyPro)
• HIV will only be cured with combinations too, conference delegates hear.  (July 2016, AIDSmap)
• Immune-Enhancing Treatment May Destabilize HIV Reservoirs.  (July 2016, NIH)
• Experimental Therapy Fails to Stop Viral Rebound Post-HIV Treatment Interruption.  (July 2016, Poz)
• 2016 HIV Cure Update: Therapeutic Vaccines and Broadly Neutralizing Antibodies.  (July 2016, TheBodyPro)
• HIV Antibody 3BNC117 Delays Viral Rebound, Could Be Component of Cure.  (June 2016, Poz)
• Weekly PRO 140 Antibody Injections Successfully Combat HIV in Some.  (June 2016, Poz); related coverage from AIDSmap
• Weekly PRO 140 Antibody Injections May Work as HIV Maintenance Therapy.  (June 2016, TheBodyPro); related coverage from Healio and MedPage Today
• Studies Begin to Test Long-Acting Antibody Infusions for HIV Prevention.  (April 2016, Poz); related coverage from NIAID
• Reflection on bNAbs [broadly neutralizing antibodies] and Broadening the Toolbox.  (March 2016, AVAC)
• A FRESH Look at Basic HIV Cure Research.  (March 2016, AVAC)
• Antibody Injections Clear HIV-Like Virus in Infant Monkeys.  (March 2016, Poz)
• Dose-finding trials of antibody-based drugs for HIV prevention will start soon.  (February 2016, AIDSmap)
• Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption.  (February 2016, AIDSmap)
• Supercharging NK cells for cure. (February 2016, Retrovirus Conference)
• Reducing HIV Viral Reservoirs with Immune-Based Therapy. (January 2016, amfAR)
• Toward an AIDS-Free Generation: Can Antibodies Help? (January 2016, NIH Director’s Blog)
• Antibody Infusion Successfully Combats HIV in Early Trial. (January 2016, Poz)
• Widely-used anti-alcoholism drug wakes up dormant HIV-infected cells. (November 2015, AIDSmap)
• A Tale of Two Diagnoses.  (November 2015, Poz)
• HIV Cure Search Sees New Protein Work on Latently Infected Cells.  (October 2015, Poz)
• Gene Therapy Controls HIV Longer Than Four Months in Study.  (September 2015, Poz)
• On the Cure Front, More Drugs Appear to Spur Latent HIV.  (September 2015, Poz)
• Discovering an Antibody With Refined Abilities to Combat HIV.  (September 2015, Poz)
• New drug holds out promise of long-term control or even cure of HIV.  (July 2015, AIDSmap)
• Keeping Latent HIV Dormant May Lead to Functional Cure.  (July 2015, Poz)
• NIH awards $7.5 million to Penn Medicine for HIV gene therapy.  (May 2015, Healio)
• HIV Vaccine Boosts Effects of Antiretrovirals.  (May 2015, Poz)
• Blocking PD-1: Progress in HIV Cure Research.  (April 2015, Beta Blog)
• HIV Antibody Infusion Shows Promise in Treating The Virus.  (April 2015, Poz)
• Compound Found to Block HIV Receptors in Monkeys.  (April 2015, Beta Blog)
• Gilead Drug Shows Promise in Reversing HIV Latency.  (March 2015, Poz)
• Experimental agents reverse HIV latency and help immune system fight HIV-infected cells.  (March 2015, AIDSmap)
• Shock & Kill: Progress in HIV Cure Research.  (March 2015, Beta Blog)
• Immune Cells Can Be Manipulated to Kill HIV-Infected Reservoir Cells.  (January 2015, Poz)
• Challenges to Stem Cell Transplantation in HIV-Positive Patients.  (October 2014, TheBody)
• Stemming the Flow From HIV Reservoirs With Neutralizing Antibodies.  (September 2014, Treatment Action Group)
• Latent HIV Reservoirs Appear to Be Reactivated by Compound Found in Plant.  (August 2014, Treatment Action Group)
• Drugs That Target HIV Reservoirs May Also Impair Killer T Cells.  (August 2014, TheBodyPro)
• Drug Spurs Latently Infected Cells But Doesn’t Taper HIV Reservoir.  (July 2014, Poz)
• Novel techniques probed in cure research.  (July 2014, AIDSmap)
• Setbacks and Progress in the Search for an HIV Cure. (July 2014, Beta Blog)
• 2 Australian Men “Cleared” of HIV After Bone Marrow Transplants.  (July 2014, TheBodyPro)
• The HDAC inhibitor romidepsin is safe and effectively reverses HIV-1 latency in vivo as measured by standard clinical assays. (July 2014, NATAP)
• Romidepsin activates latent HIV, but does not decrease viral reservoir.  (July 2014, AIDSmap)
• Jetsons-Era HIV Care and Prevention.  (April 2014, Poz)
• Failure to Awaken Dormant Cells Deals Blow to HIV Cure Research.  (March 2014, Poz)
• HIV Rebounds Detailed in Two Boston Stem Cell Transplant Patients. (March 2014, NATAP)
• Culture Shock: The Boston HIV Mystery. (March 2014, MedPage Today)
• The ‘Boston patients’ experience HIV rebound after stem cell transplants.  (March 2014, AIDSmap)
• Genetic HIV Therapy Aided by Drug to Boost CD4 Infusion.  (March 2014, Poz)
• Genetically Modifying Cells to Resist HIV Shows Promise.  (March 2014, Poz)
• A cure may need multiple components, workshop delegates hear.  (March 2014, AIDSmap)
• HIV-Specific Poison May Complement ARVs.  (January 2014, Poz)
• HIV Resurgence in “Boston Patients” Frustrates, Informs Research Into Cure.  (December 2013, Kaiser Family Foundation)
• Dashing Hopes, HIV Rebounds in 2 Men Once Potentially Cured.  (December 2013, Poz)
• CD4 gene therapy may enable functional HIV control during treatment interruption.  (September 2013, AIDSmap)
• Targeting Reactivated HIV Using Natural Killer Cells: Another Potential Cure Strategy.  (September 2013, TheBodyPro)
• Boy With HIV and Leukemia Dies After Cord Blood Transplant.  (July 2013, Poz)
• HIV’s Power Harnessed for Good in New Gene Therapies.  (July 2013, Poz)
• Two stem cell transplant recipients now controlling HIV off treatment.  (July 2013, AIDSmap)